-
PATIENT PREFERENCES FOR BENEFIT-RISK TRADE-OFFS AND EVIDENCE UNCERTAINTY OF ANTI-AMYLOID THERAPIES IN EARLY ALZHEIMER'S DISEASE: A DISCRETE CHOICE EXPERIMENT
Aug 11, 2026, 17:16 PM -
COST-EFFECTIVENESS OF ION AS A BIOPSY TOOL FOR PATIENTS CURRENTLY INELIGIBLE FOR BIOPSY IN THE LUNG CANCER DIAGNOSTIC PATHWAY
Aug 11, 2026, 17:16 PM -
UNDERSTANDING PRO RESPONSIVENESS TO CHANGE: LONGITUDINAL CONSTRUCT VALIDITY OF EORTC CORE QUALITY OF LIFE QUESTIONNAIRE (QLQ-C30) GLOBAL HEALTH STATUS/QUALITY OF LIFE (GHS/QOL) AND PAIN SCORES IN METASTATIC CASTRATION-RESISTANT PROSTATE CANCER...
Aug 11, 2026, 17:16 PM -
PROLONGED EMERGENCY DEPARTMENT LENGTH OF STAY AND ALTERNATE LEVEL OF CARE STATUS AS MARKERS OF PROLONGED HOSPITALIZATION AMONG OLDER ADULTS: AN EXPLORATORY SYNTHETIC DATA ANALYSIS
Aug 11, 2026, 17:16 PM -
HUMANISTIC BURDEN AND HEALTH RELATED QUALITY OF LIFE IN RARE DISEASES IN THE MIDDLE EAST AND NORTH AFRICA: A SCOPING REVIEW
Aug 11, 2026, 17:16 PM -
EARLY, NOT FASTER: DO CONDITIONAL MARKETING AUTHORIZATION SHORTEN TIME TO REIMBURSEMENT IN ITALY?
Aug 11, 2026, 17:16 PM -
RETURN ON INVESTMENT OF THE ICAPS PROGRAM: A COST-BENEFIT ANALYSIS OF A SCHOOL-BASED PHYSICAL ACTIVITY INTERVENTION
Aug 11, 2026, 17:16 PM -
HEALTHCARE RESOURCE BURDEN IN KIDNEY TRANSPLANT RECIPIENTS WITH ACTIVE AND CHRONIC ACTIVE ANTIBODY-MEDIATED REJECTION: RESULTS FROM A REAL-WORLD SURVEY IN GERMANY AND THE USA
Aug 11, 2026, 17:16 PM -
ELECTRONIC MEDICAL RECORD AGGREGATION VERSUS CLINICIAN DATA ENTRY: COMPARISON OF ENROLLMENT AND DATA COMPLETENESS FROM A REAL-WORLD MYASTHENIA GRAVIS REGISTRY
Aug 11, 2026, 17:16 PM -
IMPLEMENTING A COMMON DATA MODEL TO STUDY RARE DISEASE: A METHODOLOGICAL FRAMEWORK FOR THROMBOTIC MICROANGIOPATHIES IN GREECE
Aug 11, 2026, 17:16 PM -
DEVELOPING EVIDENCE-INFORMED PATIENT ENGAGEMENT GUIDANCE FOR ECONOMIC EVALUATIONS (DEEP-ENGAGE): FINDINGS FROM A SCOPING REVIEW AND AN INTERNATIONAL SURVEY
Aug 11, 2026, 17:16 PM -
ESTIMATION OF OVERALL SURVIVAL FROM INITIAL PROGRESSION-FREE SURVIVAL DATA: A BAYESIAN PARAMETRIC COPULA-BASED APPROACH LEVERAGING EARLIER-PHASE TRIAL DATA
Aug 11, 2026, 17:16 PM -
A PRACTICAL FRAMEWORK FOR INCLUDING DIETARY DATA IN REAL-WORLD EVIDENCE STUDIES: LESSONS FROM INFLAMMATORY BOWEL DISEASE AND PEDIATRIC RARE DISEASES
Aug 11, 2026, 17:16 PM -
GERMAN HTA ADDED-BENEFIT OUTCOMES FOR BIOMARKER-BASED DRUG-THERAPIES IN ONCOLOGY: HIGHER RATINGS BUT LOWER CONFIRMATION
Aug 11, 2026, 17:16 PM -
REAL-WORLD EVIDENCE ON THROMBOTIC MICROANGIOPATHIES IN GREECE: PATIENT CHARACTERISTICS AND CLINICAL OUTCOMES FROM REAL-WORLD HOSPITAL DATA OVER A 20-YEAR PERIOD
Aug 11, 2026, 17:16 PM -
A METHODOLOGY FOR DEVELOPING COMPOSITE ENDPOINT SELECTION CRITERIA INTEGRATING MULTI-STAKEHOLDER PERSPECTIVES
Aug 11, 2026, 17:16 PM -
ECONOMIC BURDEN AMONG PATIENTS WITH POLYCYTHEMIA VERA - A SYSTEMATIC REVIEW
Aug 11, 2026, 17:16 PM -
IMPACT OF BIOSIMILAR AVAILABILITY ON TREATMENT COST AMONG PATIENTS INITIATING ADALIMUMAB THERAPY IN THE US INSURED POPULATION
Aug 11, 2026, 17:16 PM -
DYNAMIC PRICING OF THE PROTEIN KINASE INHIBITOR CLASS: A RETROSPECTIVE INTERNATIONAL ANALYSIS
Aug 11, 2026, 17:16 PM -
DIFFERENTIAL POLICY RESPONSIVENESS BETWEEN BIOSIMILAR INITIATION AND SWITCHING: A PHYSICIAN SURVEY IN SOUTH KOREA
Aug 11, 2026, 17:16 PM
